InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Tuesday, 01/15/2019 1:49:22 AM

Tuesday, January 15, 2019 1:49:22 AM

Post# of 16729
Built In Partnership Potential - Re: Additional Lead Targets

My best guess for a potential partnership regarding Additional Lead Targets:

Takeda Pharmaceuticals Company

https://www.takeda.com/en-us/

On January 8, 2019, Takeda acquired Shire, a pharmaceutical company in a $62 billion deal.[24]


https://en.wikipedia.org/wiki/Takeda_Pharmaceutical_Company

Takeda Pharmaceutical is jumping into the $40 billion market for nonalcoholic steatohepatitis (NASH) and other diseases of the liver with a $470+ million investment into Virginia-based HemoShear Therapeutics LLC.


https://www.biospace.com/article/takeda-and-hemoshear-therapeutics-enter-into-exclusive-drug-discovery-partnership-in-liver-diseases/



Allergan Pharmaceuticals Company

https://www.allergan.com/home

On February 1, 2017, the company acquired LifeCell, a specialist in regenerative medicine, for $2.9 billion.[39] On April 28, the company acquired Zeltiq Aesthetics, marketer of a cryolipolysis procedure, for $2.4 billion.[40] On June 7, the company announced the acquisition of Keller Medical, a company that manufactures devices for use during breast augmentation surgery.[41] On December 12, the company announced the acquisition of Repros Therapeutics, a developer of drugs for reproductive system diseases.[42]


https://en.wikipedia.org/wiki/Allergan


/////AMG


Red Pills